
Breakthrough ALS Drug Launched on the Chinese Mainland
Tofersen, a groundbreaking gene-targeted ALS drug, launches on the Chinese mainland, offering renewed hope against this fatal disease.
News That Embraces Insight and Understanding
Tofersen, a groundbreaking gene-targeted ALS drug, launches on the Chinese mainland, offering renewed hope against this fatal disease.
Australian scientists unveil PROTEUS, a groundbreaking platform that evolves proteins in mammalian cells, paving the way for next-gen gene therapies.
China’s new gene therapy for hemophilia B marks a breakthrough in rare disease treatment, offering renewed hope for patients.